XML 28 R22.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Summary of Stock-based Compensation Expense Recognized

During the three months ended March 31, 2024 and 2023, the Company recognized the following stock-based compensation expense (in thousands):

 

 

 

For the Three Months Ended March 31,

 

 

 

 

2024

 

 

2023

 

 

Stock-based compensation expense by type of award:

 

 

 

 

 

 

 

Stock options

 

$

2,429

 

 

$

1,367

 

 

Restricted stock and restricted stock units

 

 

5,056

 

 

 

2,080

 

 

Employee stock purchase plan

 

 

496

 

 

 

122

 

 

Total stock-based compensation expense included
   in expenses

 

$

7,981

 

 

$

3,569

 

 

Stock-based compensation expense by line item:

 

 

 

 

 

 

 

Research and development expenses

 

$

2,153

 

 

$

928

 

 

General and administrative expenses

 

 

5,828

 

 

 

2,641

 

 

Total stock-based compensation expense included
   in expenses

 

$

7,981

 

 

$

3,569

 

 

Schedule of Unrecognized Stock-based Compensation Expense by Type of Award and Weighted-average Recognition Period

The following table sets forth the Company’s unrecognized stock-based compensation expense by type of award and the weighted-average period over which that expense is expected to be recognized (in thousands, except for years):

 

 

 

As of March 31, 2024

 

 

 

Unrecognized
Expense,
Net of
Estimated
Forfeitures

 

 

Weighted-
average
Recognition
Period
(in years)

 

 

 

 

 

 

 

 

Type of award:

 

 

 

 

 

 

Stock options

 

$

21,429

 

 

 

3.00

 

Restricted stock and restricted stock units

 

$

26,018

 

 

 

1.89

 

 

Summary of Stock Option Activity

The following table summarizes stock option activity during the three months ended March 31, 2024:

 

 

 

Shares Subject to Stock Options

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term (in years)

 

 

Aggregate Intrinsic Value

 

Options outstanding at December 31, 2023

 

 

5,248,682

 

 

$

6.79

 

 

 

7.10

 

 

 

62,210,000

 

Granted

 

 

1,089,200

 

 

$

18.42

 

 

 

 

 

 

 

Exercised

 

 

(821,689

)

 

$

5.31

 

 

 

 

 

 

 

Forfeited

 

 

 

 

$

 

 

 

 

 

 

 

Cancelled

 

 

 

 

$

 

 

 

 

 

 

 

Options outstanding at March 31, 2024

 

 

5,516,193

 

 

$

9.31

 

 

 

7.72

 

 

 

400,998,000

 

Options exercisable at March 31, 2024

 

 

2,634,610

 

 

$

6.75

 

 

 

6.46

 

 

 

198,264,000

 

Schedule of Weighted Average Assumptions using Black-Scholes Option Pricing Model the fair value of each employee option grant during the three months ended March 31, 2024 was estimated on the date of grant using the Black-Scholes model with the following weighted average assumptions:

 

 

 

Three Months Ended March 31, 2024

 

 

Expected volatility

 

 

82.9

 

%

Expected term (in years)

 

 

6.13

 

 

Risk-free interest rate

 

 

3.88

 

%

Expected dividend yield

 

0

 

%

Restricted stock [Member]  
Summary of Shares Granted and Stock Activity

The following table is a summary of restricted stock activity during the three months ended March 31, 2024:

 

 

 

Shares of Restricted Stock

 

 

Weighted-
Average
Grant Date
Fair Value

 

Unvested at December 31, 2023

 

 

183,095

 

 

$

0.17

 

Granted

 

 

 

 

$

 

Vested

 

 

 

 

$

 

Forfeited

 

 

 

 

$

 

Repurchased

 

 

 

 

$

 

Unvested at March 31, 2024

 

 

183,095

 

 

$

0.17

 

Restricted stock units [Member]  
Summary of Shares Granted and Stock Activity

The following table summarizes restricted stock unit activity during the three months ended March 31, 2024:

 

 

 

Shares Subject to Restricted Stock Units

 

 

Weighted-
Average
Grant Date
Value

 

Unvested at December 31, 2023

 

 

2,855,656

 

 

$

7.32

 

Granted

 

 

1,310,533

 

 

$

17.40

 

Vested

 

 

(1,259,168

)

 

$

7.27

 

Forfeited

 

 

 

 

$

 

Cancelled

 

 

(77,834

)

 

$

7.77

 

Unvested at March 31, 2024

 

 

2,829,187

 

 

$

12.00